ADCC recruits NK cells and macrophages to tumor cells, releasing DAMPs (HMGB1, ATP, CRT) that activate DCs via TLR4/cGAS–STING pathways, enhancing antigen cross-presentation and CD8+ T-cell priming [7, 93]. Here, CD8A is linked to neoplasm.